Bustelo, J., Miró Pérez, A., Meruvia Torrez, H. (2025). The Determinants of the Concentration of Superstar Firms: Cluster Analysis and … Read More
Arrobas Velilla, T., Fernández Prendes, C., Amigó Grau, N., Calmarza, P., Camós Anguila, S., Candas Estébanez, B., Castro Castro, M. … Read More
Mercè, F., Asla, Q., Illana, F., Victòria, F., Javier, H., Marta, S.,…Aulinas, A. (2025). A novel likely pathogenic germline variant … Read More
Nuciforo, P., Navarro, F., Argota, I., Alonso, L., Serna, G., Barrull, J.,…Aguado, V. (2024). Intratumoral fusobacterium as prognostic factor in … Read More
Bailón, L., Moltó, J., Curran, A., Cadiñanos, J., de Quirós, J., de los Santos, I.,…Brander, C., Mothe, B., Grp, A.-S. … Read More
Perlas, A., Reska, T., Croville, G., Tarrés-Freixas, F., Guérin, J., Majó, N., & Urban, L. (2025). Improvements in RNA and … Read More
Dienstmann, R., Ruiz-García, E., Alsina, M., Ruiz-Pace, F., Schooten, T., Martínez-Ciarpaglini, C.,…Fleitas, T. (2025). Integrated clinico-molecular analysis of gastric cancer … Read More
Cruz-Correa, M., Oh, D., Kato, K., Tabernero, J., Bai, Y., Shi, J.,…Moehler, M. (2024). Tislelizumab (TIS) plus chemotherapy (CT) vs … Read More
Tabernero, J., Yoshino, T., Kim, T., Yaeger, R., Desai, J., Wasan, H.,…Kopetz, S. (2024). Encorafenib plus cetuximab (EC) plus FOLFIRI … Read More
Amb la publicació recent de l’Action Plan for Open Repositories 2025, un full de ruta impulsat per COAR, OpenAIRE, LIBER … Read More